690 research outputs found
Involvement of Phosphatases in Proliferation, Maturation, and Hemoglobinization of Developing Erythroid Cells
Production of RBCs is triggered by the action of erythropoietin (Epo) through its binding to surface receptors
(Epo-R) on erythroid precursors in the bone marrow. The intensity and the duration of the Epo signal are regulated by several factors,
including the balance between the activities of kinesase and phosphatases. The Epo signal determines the proliferation and maturation
of the precursors into hemoglobin (Hb)-containing RBCs. The activity of various protein tyrosine phosphatases, including those involved in the
Epo pathway, can be inhibited by sodium orthovanadate (Na3VO4, vanadate). Adding vanadate to cultured erythroid precursors of normal
donors and patients with Ξ²-thalassemia enhanced cell proliferation and arrested maturation. This was associated with an increased production
of fetal hemoglobin (HbF). Increased HbF in patients with Ξ²-hemoglobinopathies (Ξ²-thalassemia and sickle cell disease) ameliorates the clinical
symptoms of the disease. These results raise the possibility that specific and nontoxic inhibitors of phosphatases may be considered as a
therapeutic modality for elevating HbF in patients with Ξ²-hemoglobinopathies
as well as for intensifying the Epo response in other forms of anemia
Uptake of Non-Transferrin Iron by Erythroid Cells
Most of the iron in the plasma is bound to transferrin (Tf) and is taken up by cells through their surface Tf receptors (TfRs). Under pathological conditions of iron-overload, the plasma iron which is in excess of the binding capacity of Tf is present as non-Tf-bound iron. We probed the uptake of non-Tf iron and its consequences on the oxidative status of peripheral RBC and reticulocytes as well as developing erythroid precursors grown in vitro. The cells were exposed to ferrous ammonium sulfate under Tf-supplemented and Tf-free conditions. Using flow cytometry techniques, we found that both the TfR-deficient mature RBC and their TfR-containing precursors at all stages of maturation can take up non-Tf iron that accumulates as redox-active labile iron and generates reactive oxygen species. Such a mechanism may account for ineffective erythropoiesis of developing precursors in the bone marrow and for the shortening of the lifespan of mature RBCs in the circulation
Red Blood Cells as Redox Modulators in Hemolytic Anemia
The oxidative status of cells, representing the balance between prooxidants and antioxidants, is involved in their normal physiological functioning, such as signal transduction, proliferation, and differentiation. When the prooxidant activity overrides the antioxidative capacity oxidative stress occurs. Chronic oxidative stress causes cytotoxicity and organ failure. As such, it is believed to play a role in various pathologies, including the hemolytic anemias. In this review, we suggest that red blood cells (RBC), in addition to their primary role as oxygen carriers, function as redox modulators. In the RBC, various systems afford it with antioxidative capacity that, in addition to balancing its own redox state, can provide antioxidative protection to the cellular and intracellular milieus throughout the body. Their vast number, mobility, occurrence throughout the body, and renewability make them good candidates for this function. A decrease in their number (anemia) or function due to oxidative stress may exacerbate the symptoms of many diseases by failing to neutralize oxidative stress. However, correcting anemia, e.g., by repeated RBC transfusions or iron supplementation, may increase the iron load, which, in turn, causes oxidative stress. This situation suggests that the status of both iron and redox should be monitored during treatment, using RBC as bioindicators
Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress
We studied the nature of enucleated RBCs containing DNA remnants, Howell-Jolly (HJ) RBCs and reticulocytes (retics), that are characteristically present in the circulation of thalassemic patients, especially after splenectomy. Using flow cytometry methodology, we measured oxidative status parameters of these cells in patients with Ξ²-thalassemia. In each patient studied, these cells had higher content of reactive oxygen species and exposed phosphatidylserine compared with their DNA-free counterparts. These results suggest that oxidative stress in thalassemic developing erythroid precursors might, through DNA-breakage, generate HJ-retics and HJ-RBCs and that oxidative stress-induced externalization of phosphatidylserine is involved in the removal of these cells from the circulation by the spleen, a mechanism similar to that of the removal of senescent RBCs
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of Ξ²-Thalassemia and Sickle-Cell Anemia
The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of Ξ²-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of Ξ²-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of Ξ²-thalassemia patients, (iii) good correlation of in vivo and in vitro results of HbF synthesis and Ξ³-globin mRNA accumulation indicates that in vitro testing might be predictive of in vivo responses and (iv) combined use of different inducers might be useful to maximize HbF, both in vitro and in vivo. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from Angelica arcangelica and Aegle marmelos, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from Streptomyces hygroscopicus
Identification and characterization of mechanistically distinct inducers of gamma-globin transcription
Inhibition of HbS polymerization is a major target for therapeutic approaches in sickle cell anemia. Toward this goal, initial efforts at pharmacological elevation of fetal hemoglobin (HbF) has sh
Therapeutic Hemoglobin Levels after Gene Transfer in Ξ²-Thalassemia Mice and in Hematopoietic Cells of Ξ²-Thalassemia and Sickle Cells Disease Patients
Preclinical and clinical studies demonstrate the feasibility of treating Ξ²-thalassemia and Sickle Cell Disease (SCD) by lentiviral-mediated transfer of the human Ξ²-globin gene. However, previous studies have not addressed whether the ability of lentiviral vectors to increase hemoglobin synthesis might vary in different patients
- β¦